7-66092577-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000048.4(ASL):​c.1164C>T​(p.His388His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,610,882 control chromosomes in the GnomAD database, including 499 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 60 hom., cov: 32)
Exomes 𝑓: 0.010 ( 439 hom. )

Consequence

ASL
NM_000048.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.46

Publications

6 publications found
Variant links:
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
ASL Gene-Disease associations (from GenCC):
  • argininosuccinic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 7-66092577-C-T is Benign according to our data. Variant chr7-66092577-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92358.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0846 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASLNM_000048.4 linkc.1164C>T p.His388His synonymous_variant Exon 16 of 17 ENST00000304874.14 NP_000039.2 P04424-1A0A024RDL8
ASLNM_001024943.2 linkc.1164C>T p.His388His synonymous_variant Exon 15 of 16 NP_001020114.1 P04424-1A0A024RDL8
ASLNM_001024944.2 linkc.1104C>T p.His368His synonymous_variant Exon 14 of 15 NP_001020115.1 P04424-2
ASLNM_001024946.2 linkc.1086C>T p.His362His synonymous_variant Exon 14 of 15 NP_001020117.1 A0A0S2Z316

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASLENST00000304874.14 linkc.1164C>T p.His388His synonymous_variant Exon 16 of 17 1 NM_000048.4 ENSP00000307188.9 P04424-1
ENSG00000249319ENST00000450043.2 linkc.477C>T p.His159His synonymous_variant Exon 7 of 12 5 ENSP00000396527.2 H7C0S8

Frequencies

GnomAD3 genomes
AF:
0.0149
AC:
2264
AN:
152116
Hom.:
60
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0240
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.0914
Gnomad SAS
AF:
0.00849
Gnomad FIN
AF:
0.0752
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00566
Gnomad OTH
AF:
0.0206
GnomAD2 exomes
AF:
0.0218
AC:
5427
AN:
248716
AF XY:
0.0199
show subpopulations
Gnomad AFR exome
AF:
0.00292
Gnomad AMR exome
AF:
0.0399
Gnomad ASJ exome
AF:
0.00587
Gnomad EAS exome
AF:
0.0872
Gnomad FIN exome
AF:
0.0674
Gnomad NFE exome
AF:
0.00616
Gnomad OTH exome
AF:
0.0241
GnomAD4 exome
AF:
0.0105
AC:
15262
AN:
1458652
Hom.:
439
Cov.:
32
AF XY:
0.0102
AC XY:
7406
AN XY:
725764
show subpopulations
African (AFR)
AF:
0.00439
AC:
147
AN:
33468
American (AMR)
AF:
0.0377
AC:
1684
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00608
AC:
159
AN:
26136
East Asian (EAS)
AF:
0.105
AC:
4149
AN:
39698
South Asian (SAS)
AF:
0.00583
AC:
503
AN:
86232
European-Finnish (FIN)
AF:
0.0688
AC:
3486
AN:
50660
Middle Eastern (MID)
AF:
0.00899
AC:
49
AN:
5448
European-Non Finnish (NFE)
AF:
0.00368
AC:
4093
AN:
1111960
Other (OTH)
AF:
0.0164
AC:
992
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
905
1809
2714
3618
4523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0149
AC:
2274
AN:
152230
Hom.:
60
Cov.:
32
AF XY:
0.0179
AC XY:
1329
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00330
AC:
137
AN:
41568
American (AMR)
AF:
0.0242
AC:
369
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3470
East Asian (EAS)
AF:
0.0914
AC:
471
AN:
5154
South Asian (SAS)
AF:
0.00830
AC:
40
AN:
4822
European-Finnish (FIN)
AF:
0.0752
AC:
798
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00566
AC:
385
AN:
68024
Other (OTH)
AF:
0.0237
AC:
50
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00797
Hom.:
11
Bravo
AF:
0.0112
Asia WGS
AF:
0.0720
AC:
249
AN:
3478
EpiCase
AF:
0.00398
EpiControl
AF:
0.00356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Dec 05, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 17, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Argininosuccinate lyase deficiency Benign:4
Nov 26, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 01, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
2.8
DANN
Benign
0.70
PhyloP100
-3.5
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75300185; hg19: chr7-65557564; API